KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 87 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $6,000 | -71.4% | 536 | -73.6% | 0.00% | – |
Q1 2021 | $21,000 | -88.3% | 2,034 | -81.7% | 0.00% | – |
Q4 2020 | $179,000 | +280.9% | 11,112 | +241.3% | 0.00% | – |
Q3 2020 | $47,000 | -82.3% | 3,256 | -76.9% | 0.00% | – |
Q2 2020 | $266,000 | +83.4% | 14,100 | +86.5% | 0.00% | – |
Q4 2019 | $145,000 | +190.0% | 7,559 | +46.7% | 0.00% | – |
Q3 2019 | $50,000 | +72.4% | 5,154 | +8.1% | 0.00% | – |
Q2 2019 | $29,000 | +383.3% | 4,770 | +599.4% | 0.00% | – |
Q4 2018 | $6,000 | 0.0% | 682 | +103.6% | 0.00% | – |
Q3 2018 | $6,000 | 0.0% | 335 | -2.6% | 0.00% | – |
Q2 2018 | $6,000 | -95.9% | 344 | -97.9% | 0.00% | – |
Q2 2017 | $148,000 | -29.5% | 16,318 | 0.0% | 0.00% | – |
Q1 2017 | $210,000 | +39.1% | 16,318 | 0.0% | 0.00% | – |
Q4 2016 | $151,000 | -5.0% | 16,318 | 0.0% | 0.00% | – |
Q3 2016 | $159,000 | +5200.0% | 16,318 | +5469.3% | 0.00% | – |
Q1 2016 | $3,000 | -50.0% | 293 | -32.3% | 0.00% | – |
Q4 2015 | $6,000 | +500.0% | 433 | +397.7% | 0.00% | – |
Q3 2015 | $1,000 | -50.0% | 87 | +17.6% | 0.00% | – |
Q2 2015 | $2,000 | 0.0% | 74 | 0.0% | 0.00% | – |
Q1 2015 | $2,000 | -33.3% | 74 | 0.0% | 0.00% | – |
Q4 2014 | $3,000 | -66.7% | 74 | -63.0% | 0.00% | – |
Q2 2014 | $9,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |